Viewing Study NCT00916032


Ignite Creation Date: 2025-12-24 @ 9:47 PM
Ignite Modification Date: 2026-02-22 @ 3:56 PM
Study NCT ID: NCT00916032
Status: COMPLETED
Last Update Posted: 2021-05-19
First Post: 2009-06-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia A
Sponsor: Baxalta now part of Shire
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-06-29
Start Date Type: ACTUAL
Primary Completion Date: 2010-04-01
Primary Completion Date Type: ACTUAL
Completion Date: 2010-04-01
Completion Date Type: ACTUAL
First Submit Date: 2009-06-05
First Submit QC Date: None
Study First Post Date: 2009-06-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2013-03-31
Results First Submit QC Date: None
Results First Post Date: 2013-09-05
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-04-28
Last Update Post Date: 2021-05-19
Last Update Post Date Type: ACTUAL